Cyient DLM Ltd

Q4 FY27 Earnings Call Analysis

Industrial Manufacturing

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 2margin: Category 1orderbook: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- No specific mention of any new fundraising through debt or equity in the current quarter or near future. - The company is currently net cash positive with strong balance sheet and has "dry powder" (available capacity) to raise working capital by another INR350-400 crores if needed. - They have sufficient land, infrastructure, and buildings in place for expansion and can add equipment quickly without large lead times. - The company is actively scouting for both organic and inorganic growth opportunities, including acquisitions, but no new deals/raises announced yet. - IPO proceeds utilization stands at 93.2%, with working capital and capex planned based on business needs. - Overall, the financial position is strong, and expansions are planned to be funded from internal accruals and available financial resources without immediate need for new fundraising.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Regular capex and maintenance ongoing at 1% to 2% of revenues. - Ability to quickly execute additional capex for specific customer needs; equipment/line additions have 3-6 months lead time. - Land, infrastructure, and building capacity already in place, enabling rapid scaling with new equipment. - Utilization of IPO proceeds: 15.4% deployed towards capex as of December 2025, with more planned in coming quarters. - Focus on investments in advanced manufacturing technologies (MES, automation, digitization) to improve efficiency and quality. - Continued investment in B2S capabilities and technology stacks to scale design-led growth. - Strategic inorganic growth pursued via acquisitions to expand geographies and capabilities; previously pursued but called off a $17.75 million M&A deal, with ongoing scouting. - Expect balanced capital deployment between organic growth, technology investment, and potential acquisitions.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- FY '27 expected to see double-digit growth in build-to-spec (B2S) revenue, increasing from around 6-7% in FY '26 to over 10%. - Strong order intake momentum with book-to-bill ratio >1.5 YTD, indicating robust revenue visibility. - Q4 FY '26 anticipated to have positive year-on-year revenue growth, marking a turnaround from recent declines. - FY '27 revenue growth expected to be substantial, driven by new sales team efforts, industry mix shift, and expansion into new geographies and segments (aerospace, industrial, medical, automotive). - Build-to-spec programs beginning revenue realization in FY '26, with significant scaling and margin expansion expected from FY '27 onwards. - Strong order book (~INR 2400 crores) with healthy margins, supporting 20-25% growth projection for FY '27. - Continued investments in sales, technology, and operational excellence to support long-term growth and improved margins.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- FY '27 expected to show slight double-digit growth in revenue with good growth from FY '28 onwards, driven by B2S programs and improved industry mix. - Margins anticipated to improve due to operating leverage, industry mix shift, and build-to-spec (B2S) ramp-up; margins to sustain around 10% range. - Strong order book and diversified customer base providing robust revenue visibility and support for future growth. - Operational efficiencies and scale benefits expected to drive further margin expansion and profitability. - Investment in sales leadership and new technologies underpins confidence in sustained growth and margin expansion. - Positive net cash position and balance sheet strength to support capacity expansion and strategic initiatives, including organic and inorganic growth. - Earnings and PAT margins expected to improve as scale returns, with normalized EBITDA margin at 10.2% in latest quarter showing potential upside.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- As of Q3 FY '26, the order book stands strong at INR 23.5 billion (approximately INR 2,350 crores), reflecting a quarter-on-quarter increase of INR 583 million. - This marks the third consecutive quarter of positive momentum in order intake. - The orders booked carry healthy and structurally improved margin profiles compared to historical levels. - The book-to-bill ratio stands at 1.56 on a year-to-date basis, indicating robust revenue visibility. - New orders and strong repeat business contributed to a healthy quarterly order intake of INR 387 crores. - The order book's margins are projected to be better than current margins, supporting double-digit profitability. - Build-to-spec revenue is currently about 6-7% of total revenue and is expected to grow to double digits in FY '27, aiding margin expansion. - The backlog supports positive growth visibility for Q4 and FY '27, with expectations of a 20-25% revenue growth in FY '27.